TJ
TREACE JAMES T Director
Board M
US US · SEC (Form 4)
€159,308
▲ Purchases (2 ops.)
Discover the detailed record of transactions filed by TREACE JAMES T, Director. Officer active across 1 companies, notably Treace Medical Concepts, INC.. Cumulatively, 30 reports have been recorded. Total volume traded: €11.7m. The latest transaction was filed on 12 May 2026 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 30 total
US$79,654 43,000 shares @ US$1.8524 0.046% mcap 3.0% of flow
Common Stock
SEC:0001193125-26-224391 · 12 May 2026
Ideal exit: 6 Feb 2027 (T+270) €79,654 43,000 shares @ €1.8524 0.046% mcap 1.5% of flow
Common Stock
SEC:0001193125-26-224391:0 · 12 May 2026
Ideal exit: 6 Feb 2027 (T+270) €267,922 20,809 shares @ €12.8753 0.16% mcap 4.2% of flow
Common Stock
SEC:0001567619-22-013208:0 · 16 Jun 2022
€435,426 30,313 shares @ €14.3643 0.25% mcap 6.8% of flow
Common Stock
SEC:0001567619-22-011883:0 · 25 May 2022
0450,000 shares 0
Common Stock
SEC:0001567619-22-006925:0 · 4 Feb 2022
033,875 shares 0
Common Stock
SEC:0001567619-22-006730:0 · 8 Mar 2022
€613,182 36,144 shares @ €16.965 0.36% mcap 21.4% of flow
Common Stock
SEC:0001567619-22-001384 · 18 Jan 2022
€613,182 36,144 shares @ €16.965 0.36% mcap 9.5% of flow
Common Stock
SEC:0001567619-22-001384:0 · 18 Jan 2022
€23,289 1,563 shares @ €14.9003 0.013% mcap 0.8% of flow
Common Stock
SEC:0001567619-21-022714 · 28 Dec 2021
€296,383 19,760 shares @ €14.9992 0.17% mcap 11.3% of flow
Common Stock
SEC:0001567619-21-022717 · 28 Dec 2021
€23,289 1,563 shares @ €14.9003 0.013% mcap 0.4% of flow
Common Stock
SEC:0001567619-21-022714:0 · 28 Dec 2021
€296,383 19,760 shares @ €14.9992 0.17% mcap 5.7% of flow
Common Stock
SEC:0001567619-21-022717:0 · 28 Dec 2021
€337,278 23,390 shares @ €14.4198 0.20% mcap 11.8% of flow
Common Stock
SEC:0001567619-21-022541 · 22 Dec 2021
€601,862 41,710 shares @ €14.4297 0.35% mcap 11.5% of flow
Common Stock
SEC:0001567619-21-022542:0 · 22 Dec 2021
€601,862 41,710 shares @ €14.4297 0.35% mcap 22.9% of flow
Common Stock
SEC:0001567619-21-022542 · 22 Dec 2021
€337,278 23,390 shares @ €14.4198 0.20% mcap 5.2% of flow
Common Stock
SEC:0001567619-21-022541:0 · 22 Dec 2021
€219,315 15,719 shares @ €13.9522 0.13% mcap 7.7% of flow
Common Stock
SEC:0001567619-21-022459 · 20 Dec 2021
€219,315 15,719 shares @ €13.9522 0.13% mcap 3.4% of flow
Common Stock
SEC:0001567619-21-022459:0 · 20 Dec 2021
€312,280 22,311 shares @ €13.9967 0.18% mcap 6.0% of flow
Common Stock
SEC:0001567619-21-022460:0 · 20 Dec 2021
€312,280 22,311 shares @ €13.9967 0.18% mcap 11.9% of flow
Common Stock
SEC:0001567619-21-022460 · 20 Dec 2021
€1m 74,526 shares @ €14.2584 0.62% mcap 16.5% of flow
Common Stock
SEC:0001567619-21-022289:0 · 15 Dec 2021
€1m 74,526 shares @ €14.2584 0.62% mcap 37.1% of flow
Common Stock
SEC:0001567619-21-022289 · 15 Dec 2021
€851,538 52,354 shares @ €16.265 0.49% mcap 32.5% of flow
Common Stock
SEC:0001567619-21-021184 · 22 Nov 2021
€851,538 52,354 shares @ €16.265 0.49% mcap 16.2% of flow
Common Stock
SEC:0001567619-21-021184:0 · 22 Nov 2021
€260,256 15,854 shares @ €16.4158 0.15% mcap 4.0% of flow
Common Stock
SEC:0001567619-21-021185:0 · 22 Nov 2021
25 of 30 declarations
Load more (5 remaining) About TREACE JAMES T James T. Treace is an executive at Treace Medical Concepts, Inc.